VANCOPHAR
ActiveSummary
VANCOPHAR has been active since 2013 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €95,790 and a net result of €189,937. Equity has been growing by about 8.2% per year since 2018. Its solvency ranks better than 32% of 12,781 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Overview
Official details
Source: KBO- Status
- Active since 11-10-2013 Normal situation
- Activity
- Retail sale of pharmaceutical products NACE 47730
- Joint committee
- 313 Paritair Comité voor de apotheken en tarificatiediensten · annual accounts 2024
- Establishment unit
- 2.229.817.192 3360 Bierbeek, since 11-10-2013
- Financial year end
- 31 December
- Peppol
- Reachable
Board and ownership
- PHARCOJAN100%· score 9831-03-2026 annual accounts of PHARCOJAN
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.3%
- Gross margin
- €284,512
- ▲ 8.9%
- Turnover
- ≈ €1.0m
- estimated
- Profit
- €189,937
- ▲ 13.1%
- Equity
- €95,790
- ▲ 11.6%
- Total assets
- €466,628
- ▲ 21.8%
- Employees on 31-12-2025
- 2
- =
Score breakdownraises riskSector: Retail trade (NACE 47)Equity €95,790 (20.5% of total assets)lowers riskLiquidity: current ratio 1.24, cash €212,519Founded in 2013Show the evidence
Checked score
About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 36% of them on solvency, 63% on liquidity, 96% on profitability and 63% on growth.
The bankruptcy probability was computed on 04-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 5 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
Key points
Recent changes
- · Gazette deed Resignation: PHARCOJAN (director)Reappointment: PHARCOJAN (statutory director) · Director discharge: PHARCOJAN
- · Gazette deed Incorporation
Comparable companies
These companies have the same main activity as VANCOPHAR: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €409,000 and €560,000, founded between 2010 and 2015.
| Company | Total assets | Gross margin |
|---|---|---|
| VANCOPHAR Bierbeek | €466,628 | €284,512 |
| APOTHEEK SINT JACOB Antwerpen | €409,362 | €291,283 |
| APOTHEEK AUGUSTYNS HOEVENEN Stabroek | €559,502 | €289,562 |
| Walemapotheek Mechelen | €491,415 | €242,339 |
| Apotheek De Voldere Wingene | €532,095 | €321,424 |
| FRENCKEN Antwerpen | €464,818 | €232,117 |
| JELY PHARMA Incourt | €469,684 | €253,186 |
Key facts about VANCOPHAR
- What is the company number of VANCOPHAR?
- The company number of VANCOPHAR is 0540.905.553. The VAT number is the same number with BE in front: BE 0540.905.553.
- Where is VANCOPHAR based?
- The registered office is at Tiensesteenweg 107, 3360 Bierbeek.Company details
- What does VANCOPHAR do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of VANCOPHAR?
- The legal form of VANCOPHAR is Private limited company (BV).
- When was VANCOPHAR founded?
- VANCOPHAR was founded on 11-10-2013.
- Is VANCOPHAR still active?
- Yes, VANCOPHAR is an active enterprise in the KBO register.
- How many employees does VANCOPHAR have?
- VANCOPHAR had an average of 1.1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does VANCOPHAR fall under?
- In its 2024 annual accounts, VANCOPHAR states joint committee 313 (Paritair Comité voor de apotheken en tarificatiediensten).
- What is the turnover of VANCOPHAR?
- The turnover in financial year 2025 is ≈ €1.0m. This figure is estimated from the gross margin of €284,512 and 47 comparable companies (NACE 477). It probably lies between €800,000 and €1.7m.
- Is VANCOPHAR profitable?
- In financial year 2025, VANCOPHAR made a profit of €189,937.
- Where can I find the annual accounts of VANCOPHAR?
- VANCOPHAR filed 12 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of VANCOPHAR due?
- VANCOPHAR must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.